A standard annual physical checks 8–14 markers — enough to confirm nothing is acutely wrong, but not much more. It screens for disease; it does not show how each system is actually performing.
A 60+ biomarker panel asks a different question: instead of “is anything broken?”, it asks “how is everything running?” Heart disease, metabolic syndrome, and hormonal decline develop gradually — often before a basic panel flags them.
This is not about finding problems where none exist. It is about having enough data to make informed decisions — especially when you are exploring TRT, BioTE hormones, or GLP-1 weight loss.